Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Day: August 21, 2025

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - August 21st 2025

🧬 This Week in Gene & Cell Therapy: Elevidys Safety Data, CAR-T Updates,…

Rare Disease news

Rare Diseases Weekly News - August 21st 2025

🧬 This Week in Rare Diseases: FDA Approvals, Global Partnerships, Breakthrough…

Cardiovascular

Cardiovascular Weekly News - August 21st 2025

Cardiovascular Update: Mounjaro CV Win, Leadless Pacemakers, Pregabalin Risk…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals
Lucid Diligence Brief: CellCarta and Pillar Biosciences strategic partnership

Tags

Ada Health Aminex Therapeutics Arrhythmia ablation Belief BioMed Chronic disease mortality CLDN18.2 conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 genome foundation model Germany biotech GLP-1 Receptor Agonists gout flares Hemab Therapeutics hyperphosphatemia Jaypirca live biotherapeutic product Liver Transplantation MicroRNAs naxtarubicin OCALIVA PPMS PRISM BioLab Rare Disease Diagnosis Rinvoq Rituximab Roche Diagnostics India Sentinel seralutinib Spikevax Stanford Medicine Sutra Medical TG Therapeutics Theriva Biologics Transfusion-Dependent Beta-Thalassemia Transgene Uncontrolled Hypertension UNFPA University Of Leicester Ver-A-T1D weight loss durability Z-Rostudirsen

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals
Lucid Diligence Brief: CellCarta and Pillar Biosciences strategic partnership

TAGS

Ada Health Aminex Therapeutics Arrhythmia ablation Belief BioMed Chronic disease mortality CLDN18.2 conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 genome foundation model Germany biotech GLP-1 Receptor Agonists gout flares Hemab Therapeutics hyperphosphatemia Jaypirca live biotherapeutic product Liver Transplantation MicroRNAs naxtarubicin OCALIVA PPMS PRISM BioLab Rare Disease Diagnosis Rinvoq Rituximab Roche Diagnostics India Sentinel seralutinib Spikevax Stanford Medicine Sutra Medical TG Therapeutics Theriva Biologics Transfusion-Dependent Beta-Thalassemia Transgene Uncontrolled Hypertension UNFPA University Of Leicester Ver-A-T1D weight loss durability Z-Rostudirsen

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy